Cigarette prohibition and the need for more prior testing of the WHO TobReg's global nicotine-reduction strategy

Lynn T Kozlowski, Lynn T Kozlowski

No abstract available

Keywords: Addiction; Global health; Illegal tobacco products; Nicotine; Public policy.

Conflict of interest statement

Competing interests: None declared.

References

    1. World Health Organization Study Group of Tobacco Product Regulation. Advisory note: global nicotine reduction strategy. Geneva, Switzerland: World Health Organization, 2015.
    1. Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med 1994;331: 123–5.
    1. Henningfield JE, Benowitz NL, Connolly GN, et al. . Reducing tobacco addiction through tobacco product regulation. Tob Control 2004;13:132–5. 10.1136/tc.2003.006890
    1. Benowitz NL, Henningfield JE. Reducing the nicotine content to make cigarettes less addictive. Tob Control 2013;22(Suppl 1):i14–17. 10.1136/tobaccocontrol-2012-050860
    1. National Cancer Institute. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine, Smoking and Tobacco Control Monograph 13. Bethesda, Maryland: US Department of Health and Human Services, National Cancer Institute, 2001.
    1. Donny EC, Denlinger RL, Tidey JW, et al. . Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med 2015;373:1340–9. 10.1056/NEJMsa1502403
    1. Heatherton TF, Kozlowski LT, Frecker RC, et al. . The test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86:1119–27. 10.1111/j.1360-0443.1991.tb01879.x
    1. Kozlowski LT, Porter CQ, Orleans CT, et al. . Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend 1994;34:211–16. 10.1016/0376-8716(94)90158-9
    1. Fagerstrom K, Russ C, Yu CR, et al. . The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. Nicotine Tob Res 2012;14:1467–73. 10.1093/ntr/nts018
    1. Lasser K, Boyd JW, Woolhandler S, et al. . Smoking and mental illness: a population-based prevalence study. JAMA 2000;284:2606–10. 10.1001/jama.284.20.2606
    1. Grant BF, Hasin DS, Chou SP, et al. . Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004;61:1107–15. 10.1001/archpsyc.61.11.1107
    1. Smith PH, Homish GG, Giovino GA, et al. . Cigarette smoking and mental illness: a study of nicotine withdrawal. Am J Public Health 2014;104:e127–33. 10.2105/AJPH.2013.301502
    1. Seeking Alpha. 22nd Century Group: a lot of smoke, not enough fire. 2014.
    1. Caraballo RS, Pederson LL, Gupta N. New tobacco products: do smokers like them? Tob Control 2006;15:39–44. 10.1136/tc.2005.012856
    1. Breland AB, Kleykamp BA, Eissenberg T. Clinical laboratory evaluation of potential reduced exposure products for smokers. Nicotine Tob Res 2006;8:727–38. 10.1080/14622200600789585
    1. Family Smoking Prevention and Tobacco Control Act, Pub L 111-31, 123 Stat 1776 21 United States Code, 2009.
    1. Kozlowski LT. Prospects for a nicotine-reduction strategy in the cigarette endgame: alternative tobacco harm reduction scenarios. Int J Drug Policy 2015;26:543–7. 10.1016/j.drugpo.2015.02.001
    1. Reuter P, Majmundar MK, National Research Council (U.S.). Committee on the Illicit Tobacco Market, et al. . Understanding the U.S. illicit tobacco market: characteristics, policy context, and lessons from international experiences. Washington DC: National Academies Press, 2015.
    1. Jha P, Chaloupka FJ. Curbing the epidemic: governments and the economics of tobacco control. World Bank Publications, 1999.
    1. Chaloupka FJ, Cummings KM, Morley CP, et al. . Tax, price and cigarette smoking: evidence from the tobacco documents and implications for tobacco company marketing strategies. Tob Control 2002;11:i62–72. 10.1136/tc.11.suppl_1.i62
    1. Joossens L, Raw M. Progress in combating cigarette smuggling: controlling the supply chain. Tob Control 2008;17:399–404. 10.1136/tc.2008.026567
    1. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2014. Vienna: United Nations Office on Drugs and Crime, 2014.
    1. Rehm J, Fischer B. Cannabis legalization with strict regulation, the overall superior policy option for public health. Clin Pharmacol Ther 2015;97:541–4. 10.1002/cpt.93
    1. Blocker JS., Jr Did prohibition really work? Alcohol prohibition as a public health innovation. Am J Public Health 2006;96:233–43. 10.2105/AJPH.2005.065409
    1. Hall W. What are the policy lessons of National Alcohol Prohibition in the United States, 1920–1933? Addiction 2010;105:1164–73. 10.1111/j.1360-0443.2010.02926.x
    1. Harp S. Globalization of the U.S. black market: prohibition, the war on drugs, and the case of Mexico. NY Univ Law Rev 2010;85:1661–93.
    1. Kozlowski LT. A policy experiment is worth a million lives. Issues Sci Technol 2016;32:20–3.
    1. Bonnie RJ, Stratton K, Kwan LY, et al. . Public health implications of raising the minimum age of legal access to tobacco products. Washington DC: The National Academies Press, 2015.
    1. Kleiman MAR, Ziskind J. Lawful access to cannabis: gains, losses and design criteria. In: LSE Expert Group on Economics of Drug Policy, ed. Ending the drug wars: report of the LSE expert group on the economics of drug policy. London: London School of Economics, 2014:77–81.
    1. Hatsukami DK, Benowitz NL, Donny E, et al. . Nicotine reduction: strategic research plan. Nicotine Tob Res 2013;15:1003–13. 10.1093/ntr/nts214
    1. Gray N, Borland R. Research required for the effective implementation of the Framework Convention on Tobacco Control, articles 9 and 10. Nicotine Tob Res 2013;15:777–88. 10.1093/ntr/nts175
    1. Kozlowski LT. Coping with the conflict-of-interest pandemic by listening to and doubting everyone, including yourself. Sci Eng Ethics 2016;22:591–6. 10.1007/s11948-015-9658-9
    1. Jarvis MJ, Bates C. Eliminating nicotine in cigarettes. Tob Control 1999;8:106–7; author reply 107–9.
    1. Shatenstein S. Eliminating nicotine in cigarettes. Tob Control 1999;8:106; author reply 107–9 10.1136/tc.8.1.106
    1. Foulds J, Ramstrom L, Burke M, et al. . Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003;12:349–59. 10.1136/tc.12.4.349
    1. Ramstrom LM, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control 2006;15:210–14. 10.1136/tc.2005.014969
    1. Lund I, Lund KE. How has the availability of snus influenced cigarette smoking in Norway? Int J Environ Res Public Health 2014;11:11705–17. 10.3390/ijerph111111705
    1. Scott JC. Seeing like a state: how certain schemes to improve the human condition have failed. New Haven: Yale University Press, 1998.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi